UP - logo
E-resources
Full text
Peer reviewed
  • Disentangling the relations...
    Bedognetti, Davide; Hendrickx, Wouter; Ceccarelli, Michele; Miller, Lance D; Seliger, Barbara

    Current opinion in immunology, 04/2016, Volume: 39
    Journal Article

    Highlights • The Th-1 cancer phenotype is characterized by responsiveness to immunotherapy. • This phenotype is accompanied by activation of counter-regulatory mechanisms. • Tumor genetic program modulates the development of the Th-1 cancer phenotype. • Oncogenic pathways can be targeted to enhance the efficacy of cancer immunotherapy.